NICM
RXDX

Neo Ivy Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Neo Ivy Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		$777K Buy
+7,068
New +$777K 0.53% 49